REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/11/2025
Voltar para busca
Dado oficial do USPTO
CELLECTIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
25/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
06/04/2018
Data de registro
24/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/11/2020
Última transação
25/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
33
Localização do titular
FR
Examinador
COLLOPY,DIANE PATRICIA
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the literal element "CELLECTIS" wherein the letters "CE ECTIS" are in dark blue and the "L's" are formed in a combination of dark blue, light blue, and medium blue.
Titulares e representantes
Titulares
CELLECTIS
Representantes
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the treatment of cancerimmune system related diseases and disorders; microorganism cultures and nutritive substances for microorganism cultures for medical and pharmaceutical use; bacteriological preparations for medical and pharmaceutical use; biological preparations for medical and pharmaceutical use for treating cancerimmune system or genetic diseases or disordersmalnutrition; chemical and biochemical preparations for medicalpharmaceuticaltherapeutic use for treating cancer and malnutrition; micro-organism preparations and cultures for medicalpharmaceutical and veterinary purposes; health foodbeveragespreparations and substancesdietetic foods for the treatment of celiac diseasenutritional supplementsmedical preparations and substances for treatment of malnutritioncancerhigh cholesterolcardiovascular diseasediabetescoronary heart diseaseimmune system related diseases and disordersnutritionally fortified beverages for medical purposes; plant-based health-food substancesdietetic foodsedible oils and fatsprocessed fruits and vegetablespreserveddried and cooked fruits and vegetablespotato based snack foodsoybeans based snack foodpotato crispspotato flakes and potato fritterspotato friescooked ready meals consisting primarily of vegetablessoya crispssoya flakessoya friescorn-based snack foodwheat based snack foodsoat based snack foodsalfalfa based snack foodscoffeecoffee substitutesseasoningssauces and condimentsmustardketchup and other tomatoes saucescooked ready meals consisting primarily of pasta or ricepotatosoyacornwheatalfalfa or oat based foodspureecornwheatalfalfa or oat crispssoyacornwheatalfalfa and oat flourcornwheatalfalfa and oat flakescornwheatalfalfa and oat friesadapted for medical use; dietary supplements; nutritional supplements; nutritional additives in the nature of dietary and nutritional supplements for medical purposes; cultures and preparations of micro-organisms for medical or therapeuticpharmaceutical and veterinary usehuman and animal cells in the nature of biological tissue cultures for the treatment of cancerimmune system related diseases and disorders; bacteriological preparations for in vivo and in vitro genetic engineeringfor medicalpharmaceutical and veterinary purposes; medicines for veterinary use for treating cancer and malnutrition; medicines for human use for treating cancer and malnutrition; Diagnostic preparations for the treatment of cancerimmune system related diseases and disordersmalnutrition; Pharmaceutical products for medical purposes in the nature of enzymesnatural and engineered nucleasesnucleic acid vectorsmolecular scissors; Chemical and pharmaceutical products for medical purposes in the nature of enzymesnatural and engineered nucleasesnucleic acid vectors and molecular scissors; Veterinary productsnucleic acid sequences being enzymesstem cellschemical and biological reagentsbacteriayeastsenzymesbacteriological preparationsnatural and engineered endoncucleases being enzymes
Classe 42
Technical studies and evaluation of new products in the pharmaceutical industry; engineering services; computer programming; Design and development of computer software and hardware; scientific and industrial research in the agri-foodhorticulture and agriculture sector for genome modification of cells of all types; geneticmedical and pharmaceutical research; research in chemistrybiologybiochemistrymolecular biology or bacteriology; research and development in biochemical analysisbiological analysis and molecular biology techniques; Research and development of new compounds for use in industryagriculture and horticulture; scientific laboratory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/10/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
18/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/02/2021
FIMP
FINAL DISPOSITION PROCESSED
24/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
24/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2020
PUBO
PUBLISHED FOR OPPOSITION
08/09/2020
GPNX
NOTIFICATION PROCESSED BY IB
05/09/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/08/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2020
ALIE
ASSIGNED TO LIE
27/07/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/07/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/03/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/03/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
31/01/2020
GNFR
FINAL REFUSAL E-MAILED
31/01/2020
CNFR
FINAL REFUSAL WRITTEN
31/01/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2019
ALIE
ASSIGNED TO LIE
11/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2019
RFNT
REFUSAL PROCESSED BY IB
28/06/2019
CNRT
NON-FINAL ACTION MAILED
30/05/2019
CNRT
NON-FINAL ACTION WRITTEN
29/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2019
RFNT
REFUSAL PROCESSED BY IB
08/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/11/2018
RFRR
REFUSAL PROCESSED BY MPU
15/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/10/2018
CNRT
NON-FINAL ACTION WRITTEN
30/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
27/10/2018
DOCK
ASSIGNED TO EXAMINER
23/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLECTIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.